Is anti-alphafetoprotein immunoscintigraphy a promising approach for the diagnosis of hepatoma? Implications of a quantitative study in 41 patients.

MLA

Demangeat, J. L., et al. “Is Anti-Alphafetoprotein Immunoscintigraphy a Promising Approach for the Diagnosis of Hepatoma? Implications of a Quantitative Study in 41 Patients.” European Journal of Nuclear Medicine, vol. 14, no. 12, 1988, pp. 612–20. EBSCOhost, https://doi.org/10.1007/BF00251785.

APA

Demangeat, J. L., Manil, L., Demangeat, C., Rico, E., Staedel-Flaig, C., Duclos, B., Brunot, B., Jaeck, D., Bellet, D., & Constantinesco, A. (1988). Is anti-alphafetoprotein immunoscintigraphy a promising approach for the diagnosis of hepatoma? Implications of a quantitative study in 41 patients. European Journal of Nuclear Medicine, 14(12), 612–620. https://doi.org/10.1007/BF00251785

Chicago

Demangeat, J L, L Manil, C Demangeat, E Rico, C Staedel-Flaig, B Duclos, B Brunot, D Jaeck, D Bellet, and A Constantinesco. 1988. “Is Anti-Alphafetoprotein Immunoscintigraphy a Promising Approach for the Diagnosis of Hepatoma? Implications of a Quantitative Study in 41 Patients.” European Journal of Nuclear Medicine 14 (12): 612–20. doi:10.1007/BF00251785.